CERES BRAIN Therapeutics
Innovative creatine brain treatment
- B2B
About CERES BRAIN Therapeutics
Development of creatine-based therapies targeting cerebral diseases like Creatine Transporter Deficiency and ALS, with preclinical success and clinical progress.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2019
- Revenue
- $4.5M – $25.9MTamtam estimate
- Website
- ceres-brain.com
CERES BRAIN Therapeutics at a glance
CERES BRAIN Therapeutics is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Paris, Île-de-France, France.
CERES BRAIN Therapeutics was founded in 2019.
CERES BRAIN Therapeutics has 11–50 employees.
CERES BRAIN Therapeutics's revenue is $4.5M – $25.9M (Tamtam estimate).
Frequently asked questions about CERES BRAIN Therapeutics
What is CERES BRAIN Therapeutics's revenue?
Tamtam estimates CERES BRAIN Therapeutics's annual revenue at $4.5M – $25.9M.
How many employees does CERES BRAIN Therapeutics have?
CERES BRAIN Therapeutics has 11–50 employees.
Where is CERES BRAIN Therapeutics headquartered?
CERES BRAIN Therapeutics is headquartered in Paris, Île-de-France, France.
Selling to companies like CERES BRAIN Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies